BCM
Bayesian Capital Management’s Integra LifeSciences IART Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Buy |
+18,437
| New | +$226K | 0.04% | 436 |
|
|
2025
Q1 | – | Sell |
-32,500
| Closed | -$737K | – | 770 |
|
|
2024
Q4 | $737K | Buy |
+32,500
| New | +$737K | 0.09% | 296 |
|
|
2024
Q1 | – | Sell |
-12,700
| Closed | -$553K | – | 927 |
|
|
2023
Q4 | $553K | Buy |
+12,700
| New | +$553K | 0.06% | 359 |
|
|
2023
Q1 | – | Sell |
-31,758
| Closed | -$1.78M | – | 933 |
|
|
2022
Q4 | $1.78M | Buy |
+31,758
| New | +$1.78M | 0.26% | 80 |
|
|
2022
Q3 | – | Sell |
-4,567
| Closed | -$247K | – | 847 |
|
|
2022
Q2 | $247K | Buy |
+4,567
| New | +$247K | 0.05% | 543 |
|
|
2021
Q2 | – | Sell |
-2,954
| Closed | -$204K | – | 513 |
|
|
2021
Q1 | $204K | Buy |
+2,954
| New | +$204K | 0.05% | 456 |
|
|
2017
Q1 | – | Sell |
-6,400
| Closed | -$549K | – | 536 |
|
|
2016
Q4 | $549K | Buy |
6,400
+606
| +10% | +$52K | 0.14% | 284 |
|
|
2016
Q3 | $478K | Buy |
+5,794
| New | +$478K | 0.31% | 113 |
|